PRESS RELEASE published on 06/17/2025 at 23:00, 10 months 29 days ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
BRIEF published on 05/21/2025 at 23:05, 11 months 26 days ago Medicure annonce ses résultats financiers du premier trimestre 2025 et les résultats de l'élection des administrateurs Perte Nette Élection Du Directeur Résultats Financiers De Medicure Baisse Des Ventes D'AGGRASTAT Revenus Des Pharmacies
BRIEF published on 05/21/2025 at 23:05, 11 months 26 days ago Medicure Announces Q1 2025 Financial Results and Director Election Outcomes Net Loss Director Election Medicure Financial Results AGGRASTAT Sales Decline Pharmacy Revenue
PRESS RELEASE published on 05/21/2025 at 23:00, 11 months 26 days ago Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2025 results with $5.5M net revenue, elects directors, and details financial performance. AGGRASTAT and ZYPITAMAG sales analyzed Medicure Inc. Net Revenue AGGRASTAT ZYPITAMAG Q1 2025 Results
BRIEF published on 04/25/2025 at 23:06, 1 year ago Medicure Inc. dévoile ses résultats financiers pour 2024 Medicure Inc. 2024 Marley Drug Financials Ventes D'AGGRASTAT® Chiffre D'affaires De ZYPITAMAG® Baisse De L'EBITDA Ajusté
BRIEF published on 04/25/2025 at 23:06, 1 year ago Medicure Inc. Reveals Financial Results for 2024 Medicure Inc. 2024 AGGRASTAT® Sales ZYPITAMAG® Revenue Marley Drug Financials Adjusted EBITDA Decline
PRESS RELEASE published on 04/25/2025 at 23:01, 1 year ago Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024 Medicure Inc. reports total net revenue of $21.9 million for year ended Dec 31, 2024. AGGRASTAT & Marley Drug sales increase, while Adjusted EBITDA declines Adjusted EBITDA Medicure Inc. Marley Drug Net Revenue AGGRASTAT
BRIEF published on 04/23/2025 at 00:05, 1 year ago Medicure annoncera ses résultats financiers pour 2024 Résultats Financiers Conférence Téléphonique Medicure AGGRASTAT® Produits Pharmaceutiques Américains
BRIEF published on 04/23/2025 at 00:05, 1 year ago Medicure to Announce 2024 Financial Results Financial Results Conference Call Medicure AGGRASTAT® U.S. Pharmaceuticals
PRESS RELEASE published on 04/23/2025 at 00:00, 1 year ago Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024 Medicure Inc. to present 2024 Year End Financial Results on April 29, 2025 via conference call. Focus on pharmaceuticals & healthcare products in US market Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2024 Year End Financial Results
Published on 05/16/2026 at 01:15, 23 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 1 hour ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 1 hour ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 8 hours 7 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 4 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 6 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 9 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 9 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 14 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 15 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 6 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
